Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-10-050454

Options or other derivatives

  • CEO and President acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Chan Phillip P. CEO and President 2010-09-17 Grant or award · Convertible Note Plus Warrants +100,000 $10,000.00 $1,000,000,000 6,568,858 D: show line 1 in the form
Loading xslF345X03/v197241_ex.xml…